A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : DHE

Search Conditions:
Search Keyword : DHE
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: DHE
Appearance Frequency: 835 time(s)
Long forms: 72

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
dihydroethidium
(347 times)
Pharmacology
(60 times)
ROS (174 times)
NO (39 times)
SOD (24 times)
1986 Relationship between dihydroetorphine and cholinergic system in the inhibition of respiration and heart rate.
dihydroergotamine
(229 times)
Neurology
(64 times)
DVT (14 times)
NSAIDs (8 times)
5-HT (5 times)
1964 "RETINAL REANIMATION" IN THE SURGICAL TREATMENT OF GLAUCOMA: FIRST RESULTS OBTAINED WITH THE POSTOPERATIVE ADMINISTRATION OF DIHYDROERGOTAMINE (DHE).
dehydroergosterol
(55 times)
Biochemistry
(24 times)
PM (8 times)
CTL (5 times)
FRET (5 times)
1983 Incorporation of danyslated phospholipids and dehydroergosterol into membranes using a phospholipid exchange protein.
dihematoporphyrin ether
(49 times)
General Surgery
(13 times)
PDT (20 times)
HPD (8 times)
BM (4 times)
1984 Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model.
dihydroergotamine mesylate
(21 times)
Neurology
(9 times)
ET (2 times)
AUC (1 time)
BA (1 time)
1975 Failure of ergotamine to act as an amplifier of sulfonylurea-stimulated insulin secretion.
delayed hyperenhancement
(13 times)
Diagnostic Imaging
(8 times)
CMR (3 times)
LV (3 times)
IR (2 times)
2005 Delayed contrast-enhanced magnetic resonance imaging for the detection of autoimmune myocarditis and long-term follow-up.
dihydroergocryptine
(13 times)
Endocrinology
(5 times)
DA (2 times)
AP (1 time)
DHA (1 time)
1977 [3H]dihydroergocryptine binding in rat brain.
dental health education
(12 times)
Dentistry
(10 times)
GI (3 times)
PI (3 times)
ECC (2 times)
1985 Active-involvement principle in dental health education.
dihydro-beta-erythroidine
(7 times)
Physiology
(4 times)
ACh (4 times)
MLA (2 times)
nAChR (2 times)
1968 Pharmacology of pH effects on carotid body chemoreceptors in vitro.
10  dihematoporphyrin-ester and -ether
(4 times)
Otolaryngology
(2 times)
--- 1988 [Photodynamic destruction of in vitro cultivated squamous cell carcinoma cells of the head and neck area].
11  dioxinodehydroeckol
(4 times)
Biochemistry
(2 times)
ACS1 (1 time)
BMP (1 time)
ERK (1 time)
2009 Inhibitory effects of phloroglucinol derivatives isolated from Ecklonia stolonifera on Fc(epsilon)RI expression.
12  dehydroeffusol
(3 times)
Biochemistry
(2 times)
ATF2 (1 time)
ATF4 (1 time)
DDIT3 (1 time)
2016 Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis.
13  dihematoporphyrin ether/ester
(3 times)
Microbiology
(1 time)
HPD (1 time)
PDT (1 time)
1988 In vitro characterization of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy.
14  dihydroethidium fluorescence
(3 times)
Pharmacology
(1 time)
AMPK (1 time)
AT1R (1 time)
CPP (1 time)
2014 Exercise training reduces cardiac dysfunction and remodeling in ovariectomized rats submitted to myocardial infarction.
15  dihydroetorphini hydrochloride
(3 times)
Gynecology
(2 times)
CINA (1 time)
IM (1 time)
1994 [Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
16  Distributed Healthcare Environment
(3 times)
Health Services Research
(3 times)
CEN (1 time)
HANSA (1 time)
HIS (1 time)
1997 Experiences with DHE: an order entry and result reporting case study.
17  dynamic headspace extraction
(3 times)
Chemistry
(3 times)
GC-MS (2 times)
SPE (2 times)
SPME (2 times)
2012 Volatile compounds in low-acid fermented sausage "espetec" and sliced cooked pork shoulder subjected to high pressure processing. A comparison of dynamic headspace and solid-phase microextraction.
18  2',7'-dichlorodihydrofluorescein (H(2)DCF), and dihydroethidium
(2 times)
Biochemistry
(1 time)
DCF (1 time)
DHR (1 time)
Mx (1 time)
2003 Time-dependent interactions of oxidant-sensitive fluoroprobes with inhibitors of cellular metabolism.
19  3H-dihydroergocryptine
(2 times)
Medicine
(1 time)
DHA (1 time)
1984 [Is the alpha adrenergic receptor density increased in intact thrombocytes in non-isometric trained athletes?].
20  dehydrocostuslactone
(2 times)
Neoplasms
(2 times)
ER (1 time)
IRE1 (1 time)
PERK (1 time)
2009 Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells.
21  dehydroemetine
(2 times)
Pharmacy
(1 time)
--- 1967 Oral dehydroemetine (DHE) in intestinal and extra intestinal amebiasis. A preliminary report.
22  Dehydroevodiamine
(2 times)
Complementary Therapies
(1 time)
APD (1 time)
CAVB (1 time)
EADs (1 time)
2014 Gram-scale purification of dehydroevodiamine from Evodia rutaecarpa fruits, and a procedure for selective removal of quaternary indoloquinazoline alkaloids from Evodia extracts.
23  District Health Executive
(2 times)
Health Services
(1 time)
CFR (1 time)
IRB (1 time)
PMD (1 time)
2007 The challenge of measuring quality of care at health centre level in Africa: the example of Tsholotsho health district in Matabeleland North, Zimbabwe.
24  dynamic handgrip exercise
(2 times)
Physiology
(1 time)
HTN (2 times)
CFI (1 time)
EPR (1 time)
2003 Exercise-induced human coronary collateral function: quantitative assessment during acute coronary occlusions.
25  heparin-dihydroergotamine
(2 times)
General Surgery
(1 time)
--- 1982 Prevention of fatal postoperative pulmonary embolism by heparin dihydroergotamine or Dextran 70.
26  3,4-dihydroxyethylamphetamine
(1 time)
Technology
(1 time)
DHA (1 time)
FPIA (1 time)
HMA (1 time)
1996 Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.
27  9(11)-dehydroergosterol
(1 time)
Biochemistry
(1 time)
8-DED (1 time)
EEP (1 time)
2000 Effects of singlet oxygen on membrane sterols in the yeast Saccharomyces cerevisiae.
28  agent--dihydroetorphine hydrochloride
(1 time)
Neoplasms
(1 time)
ART (1 time)
1991 [Dihydroetorphine hydrochloride for moderate and severe cancer pain].
29  Damaging geo-Hydrological Event
(1 time)
Environmental Health
(1 time)
--- 2015 Storminess and geo-hydrological events affecting small coastal basins in a terraced Mediterranean environment.
30  days to heading
(1 time)
Genetics
(1 time)
DMA (1 time)
PHE (1 time)
QE (1 time)
2017 Mapping QTLs associated with agronomic and physiological traits under terminal drought and heat stress conditions in wheat (Triticum aestivum L.).
31  DCFH and hydroethidine
(1 time)
Gastroenterology
(1 time)
BSO (1 time)
DCFH (1 time)
ROS (1 time)
1997 Cycloheximide prevents apoptosis, reactive oxygen species production, and glutathione depletion induced by transforming growth factor beta in fetal rat hepatocytes in primary culture.
32  Defence Healthcare Engagement
(1 time)
Military Medicine
(1 time)
DMS (1 time)
HH (1 time)
VIP (1 time)
2018 Nursing and medical contribution to Defence Healthcare Engagement: initial experiences of the UK Defence Medical Services.
33  degree of solanidine hydrolytic extraction
(1 time)
Chemistry
(1 time)
--- 2003 Solanidine hydrolytic extraction and separation from the potato (Solanum tuberosum L.) vines by using solid-liquid-liquid systems.
34  dehydration heat exposure group
(1 time)
Biomedical Technology
(1 time)
CN (1 time)
DBP (1 time)
HE (1 time)
2016 Effect of dehydration heat exposure on thoracic aorta reactivity in rats.
35  Dehydrocostus lactone
(1 time)
Neoplasms
(1 time)
BBB (1 time)
2017 Dehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma, through inhibition of the NF-kappaB/COX-2 signaling pathway by targeting IKKbeta.
36  dehydroepiandrosterone
(1 time)
Biochemistry
(1 time)
3alphaHSD (1 time)
2003 Steroid production in toads.
37  delayed hyper-enhancement imaging
(1 time)
Diagnostic Imaging
(1 time)
CMR (1 time)
HCM (1 time)
LV (1 time)
2012 Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.
38  delayed type hypersensitivity effectors
(1 time)
Biology
(1 time)
CY (1 time)
SRBC (1 time)
1979 [Effect of thymectomy on induction of immunologic tolerance in the effectors of delayed hypersensitivity].
39  delta8,9-dehydroestrone
(1 time)
Reproductive Medicine
(1 time)
SCE-B (1 time)
Tmax (1 time)
2010 Pharmacokinetics of a modified-release estrogen tablet.
40  dental health education programme
(1 time)
Dentistry
(1 time)
B/C (1 time)
C/E (1 time)
CMF (1 time)
2006 Cost-effectiveness of a long-term dental health education program for the prevention of early childhood caries.
41  dependent on the incubating media
(1 time)
General Surgery
(1 time)
PDT (1 time)
1989 In vitro photodynamic therapy of human lung cancer.
42  derivatives ergotamine, dihydroergotamine
(1 time)
Pharmacology
(1 time)
5-HT (1 time)
EDRF (1 time)
1996 Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.
43  developed habit engram
(1 time)
Biology
(1 time)
RA (1 time)
1989 [Characteristics of memory in MRL/1 mice and the effect of thymic peptides].
44  DHE washout
(1 time)
General Surgery
(1 time)
IL (1 time)
PDT (1 time)
SF (1 time)
1989 Potentiation of phototherapy cytotoxicity with light scattering media.
45  di-n-hexyl ether
(1 time)
Chemistry Techniques, Analytical
(1 time)
CZE (1 time)
SLM (1 time)
TOPO (1 time)
1995 Supported liquid membrane technique for selective sample workup of basic drugs in plasma prior to capillary zone electrophoresis.
46  diabetic heavy exercise
(1 time)
Endocrinology
(1 time)
CHE (1 time)
CS (1 time)
DS (1 time)
2010 The effects of heavy long-term exercise on ventricular myocyte shortening and intracellular Ca2+ in streptozotocin-induced diabetic rat.
47  differential Hall effect measurement method
(1 time)
Nanotechnology
(1 time)
--- 2018 A differential Hall effect measurement method with sub-nanometre resolution for active dopant concentration profiling in ultrathin doped Si1-x Ge x and Si layers.
48  differentially heated enclosure problem
(1 time)
Physics
(1 time)
RB (1 time)
2010 Natural convection heat transfer simulation using energy conservative dissipative particle dynamics.
49  difficult hypopharyngeal exposure group
(1 time)
Neoplasms
(1 time)
non-DHE (1 time)
TMD (1 time)
2019 Preoperative predictors of difficult hypopharyngeal exposure by retractor for transoral robotic surgery.
50  Dihydergot
(1 time)
Medicine
(1 time)
PRA (1 time)
1985 Urinary electrolyte excretion and orthostatic response of blood pressure and plasma renin activity in children with postural hypotension before and after treatment with Dihydergot.
51  dihydro-beta-erythroidine hydrobromide
(1 time)
Toxicology
(1 time)
BCh (1 time)
DAMP (1 time)
IP3 (1 time)
2004 Acute exposure to methylmercury causes Ca2+ dysregulation and neuronal death in rat cerebellar granule cells through an M3 muscarinic receptor-linked pathway.
52  dihydroergocriptine
(1 time)
Urology
(1 time)
DHA (1 time)
PZP (1 time)
QNB (1 time)
1988 Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding.
53  dihydroergotamine alone
(1 time)
General Surgery
(1 time)
--- 1985 United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
54  dihydroergotamine methanosulphonate
(1 time)
Physiology
(1 time)
i.c.v (1 time)
MX (1 time)
1985 The hypothalamic and neurohypophysial vasopressin and oxytocin content under various states of adrenergic transmission in dehydrated and subsequently rehydrated rats.
55  Dihydroergotamine-treatment
(1 time)
Obstetrics
(1 time)
--- 1989 [Effect of dihydroergotamine (DHE) on fetal hemodynamics].
56  dihydroergotoxine mesylate
(1 time)
Neurology
(1 time)
CMEs (1 time)
IDL (1 time)
LIS (1 time)
1993 [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
57  dihydroethidium assay
(1 time)
Biochemistry
(1 time)
NO (1 time)
OTA (1 time)
PT (1 time)
2018 Effect of rMnSOD on Sodium Reabsorption in Renal Proximal Tubule in Ochratoxin A-Treated Rats.
58  dihydroethidium probe
(1 time)
Biochemistry
(1 time)
CM (1 time)
LDH (1 time)
MT (1 time)
2008 Involvement of microtubules in the tolerance of cardiomyocytes to cold ischemia-reperfusion.
59  Dihydrogen ethidium
(1 time)
Clinical Medicine
(1 time)
CTS (1 time)
ROS (1 time)
2015 Effects of cryptotanshinone on the expression levels of inflammatory factors in myocardial cells caused by Ang II and its mechanism.
60  dihydrogenated ergot alkaloid dihydroergotamine
(1 time)
Internal Medicine
(1 time)
--- 1984 [Experimental pharmacological studies of the venous tonus-modifying effect of dihydroergotamine].
61  dihydroxy ephedrine
(1 time)
Pharmacology
(1 time)
DHPE (1 time)
1971 Effect of (plus or minus) dihydroxy ephedrine and (plus or minus) dihydroxy pseudoephedrine on adrenergic transmission in mesenteric arteries.
62  dilution-heating-endpoint
(1 time)
Communicable Diseases
(1 time)
AE (1 time)
AK (1 time)
APB (1 time)
3)-beta-D-glucan levels in plasma]. -->2005 [Non-specific reactions in four methods measuring (1-->3)-beta-D-glucan levels in plasma].
63  dispersion halo effect
(1 time)
Dentistry
(1 time)
--- 2008 Influence of kinetic cavity preparation devices on dental topography: an in vitro study.
64  docosahexaenoic acid
(1 time)
Neoplasms
(1 time)
EPA (1 time)
OSCC (1 time)
sPLA2 (1 time)
2015 Tissue fatty acid composition and secretory phospholipase-A2 activity in oral squamous cell carcinoma.
65  dormancy hygiene education
(1 time)
Complementary Therapies
(1 time)
CGI (1 time)
PSQI (1 time)
TWBXD (1 time)
2011 [Intervention of tianwang buxin decoction combined with dormancy hygiene education for treatment of sub-healthy insomnia patients of yin deficiency fire excess syndrome].
66  dorsal horn-enriched
(1 time)
Biology
(1 time)
ISH (1 time)
PCR (1 time)
2006 Molecular mapping of developing dorsal horn-enriched genes by microarray and dorsal/ventral subtractive screening.
67  dose heparin plus dihydroergotamine
(1 time)
Hematology
(1 time)
s.c (1 time)
VT (1 time)
1992 Apparent lack of synergism between heparin and dihydroergotamine in prevention of deep vein thrombosis after elective hip replacement: a randomised double-blind trial reported in conjunction with an overview of previous results.
68  dried hot extract
(1 time)
Nutritional Sciences
(1 time)
DCE (1 time)
FCE (1 time)
FHE (1 time)
2011 Hot and cold water infusion aroma profiles of Hibiscus sabdariffa: fresh compared with dried.
69  dual-frequency heterodyne ellipsometer
(1 time)
Biophysics
(1 time)
--- 2009 Dual-frequency heterodyne ellipsometer for characterizing generalized elliptically birefringent media.
70  dural herniations and encephaloceles
(1 time)
Otolaryngology
(1 time)
--- 2002 Dural herniations, encephaloceles: an index of neglected chronic otitis media and further complications.
71  hydroethidine-dihydroethidium
(1 time)
Radiology
(1 time)
IONs (1 time)
ROS (1 time)
2016 Fluorescence imaging of reactive oxygen species byconfocal laser scanning microscopy for track analysis of synchrotron X-ray photoelectric nanoradiatordose: X-ray pump-optical probe.
72  low-dose heparin or heparin-dihydroergotamin
(1 time)
General Surgery
(1 time)
--- 1983 Low-dose heparin prophylaxis and postoperative wound hematoma.